CClinicalTrials.gg
CompletedNCT03933124VIRTUALUpdated Sep 16, 2021

The Effect of Virtual Reality on Post-surgical Pain and Recovery.

An interventional study of Virtual Reality in Pain, Post-surgical Pain and Pain Management, sponsored by Radboud University Medical Center. Completed at 1 site in Netherlands. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2021-09-16.

Sponsored by Radboud University Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

This study evaluates the effect of Virtual Reality (VR) on pain and recovery in 100 post-operative patients. 60 patients will be included in the intervention group; they will use VR minimal 3 times a day on day 2-4 after surgery, on the surgical ward, as an add-on intervention next to standard care. 40 patients in the control group will only receive standard postoperative care.

Read the detailed description

Adequate management of post-surgical pain (PSP) may contribute to improved clinical and socioeconomic outcomes. Facilitating an adequate level of PSP relief is a challenging problem: the analgesics that are most frequently used, for example, opioids and non-steroidal anti-inflammatory drugs (NSAIDs), often come with side effects and do not always provide sufficient pain relief. Therefore, pain management is increasingly focusing on (additional) non-pharmacological analgesics, including Virtual Reality (VR).

VR immerses the user in a virtual world through a head mounted device (HMD). VR is, among other things, taught to be effective through distraction: it diverts attention away from the nociceptive input, resulting in less available attention for pain perception. In both clinical and experimental studies, VR has shown to be effective in reducing pain, anxiety and stress.

Although this distraction method is increasingly studied in the past years, VR pain relief has mostly been investigated as an intervention during painful procedures in specific research populations. For example, VR has been studied during wound dressing changes in burn wound patients in children and adolescents, during venipuncture in children or during dental treatments. Furthermore, most VR studies used VR as a single intervention, measuring pre-post differences in pain scores or used a cross over design with one VR session and one control session. It is interesting to know whether VR is effective in reducing postoperative pain during more than one VR session. More research is needed in larger trials evaluating a broad sample of the general population including elderly, as the common hospitalized patient is of an older age nowadays. Finally, it is important to evaluate the feasibility and acceptability of VR in postoperative patients and to know whether there are predictive factors to select patients who can mostly benefit from VR interventions.

02

Conditions studied

  • Pain
  • Post-surgical Pain
  • Pain Management

Browse trials for

Keywords

  • Post-surgical pain
  • Virtual Reality
  • Distraction
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 100 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient underwent surgery
  • Patient reports a postoperative pain score ≥4 on the first postoperative day at the surgical ward and pain score should also be marked with 'pain is not acceptable'.
  • At the day of recruitment, the estimated length of stay is at least 4 days after inclusion.
  • Patient is willing and able to comply with the trial protocol.
  • Patient is at least 16 years old on the day the informed consent form will be signed.

Exclusion criteria

Exclusion Criteria:

  • Patient suffers from delirium or acute confusional state.
  • Patient has (a history of) dementia, seizure or epilepsy.
  • Patient with severe hearing/visual impairment not corrected.
  • Patient is placed in isolation.
  • The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
  • Unplanned (re)admission to the intensive care unit (ICU).
  • Inclusion in another trial to evaluate new ways of treating pain
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Virtual Reality Intervention group

    The intervention group includes 60 patients who will use Virtual Reality for postoperative pain. Participants will use Virtual Reality minimal 10 minutes, minimal 3 times a day on the second, third and fourth day after surgery, on the general ward. * 20 participants will receive an Oculus Go immersive 3D nature videos, games, meditation videos, google earth experiences and sports games. * 20 participants will receive a Relaxmaker with 2D nature videos * 20 participants will receive CareVRx with 3D nature videos and meditation videos.

    Device: Virtual Reality

  • No intervention
    Control group

    The control group receives standard postoperative care.

Interventions

  • DeviceVirtual Reality

    The Virtual Reality intervention is used for 10 minutes minimal 3 times a day on postoperative day 2-4.

    Also known as: Relaxmaker, Oculus Go, CareVRx

06

What researchers measure

Primary outcomes

  1. Mean Daily pain score (VAS, visual analogue scale)

    Pain on average in the last 24h. VAS (visual analogue scale): 0-100 mm, 0 is defined as "no pain at all", 100 is "the worst pain the patient can imagine".

    Time frame: day 1-4, the first four postoperative days on the surgical ward

Secondary outcomes

  1. Time to 30% pain reduction compared to pain scores on postoperative day 1.

    Time to 30% pain reduction compared to pain scores on postoperative day 1.

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  2. Mean Daily worst pain score (VAS)

    Worst pain in the last 24h.

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  3. Effect of pain on mobility (NRS, Numeric Rating Scale)

    NRS score (Numeric Rating Scale): 0-10. 0 is defined as "no pain at all", 10 is "the worst pain the patient can imagine".

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  4. Difference in pain scores pre- and post- VR intervention (VAS)

    Pain pre- and postintervention in the VR intervention group.

    Time frame: Day 2-4 on the surgical ward.

  5. Quality of recovery -15 questionnaire.

    Quality of recovery -15 questionnaire.

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  6. Mean Daily Anxiety score (VAS).

    Anxiety on average in the last 24h.

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  7. Mean Daily Stress score (VAS)

    Stress on average in the last 24h.

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  8. State-Trait Anxiety Inventory (STAI)-6 questionnaire.

    State-Trait Anxiety Inventory (STAI)-6 questionnaire.

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  9. Difference in anxiety scores pre- and post- VR intervention. (VAS)

    Anxiety pre- and postintervention in the VR intervention group.

    Time frame: Day 2-4 on the surgical ward.

  10. Difference in stress scores pre- and post- VR intervention. (VAS)

    Stress pre- and postintervention in the VR intervention group.

    Time frame: Day 2-4 on the surgical ward.

  11. Difference in depression scores pre- and post- VR intervention. (VAS)

    Depression pre- and postintervention in the VR intervention group.

    Time frame: Day 2-4 on the surgical ward.

  12. Analgesic use

    Analgesic use (paracetamol, NSAIDs, opioids, use of add-on/escape medication, daily defined dose of opioid, days to removal of epidural analgesia or PCA (patient-controlled intravenous analgesia, morphine IV), days to converting from opioids to NSAIDs or paracetamol without opioids).

    Time frame: day 1-4, the first four postoperative days on the surgical ward.

  13. Feasibility of VR

    Questionnaire, interview

    Time frame: Day 1-4 postoperative

  14. Patients acceptability

    Questionnaire, interview

    Time frame: Day 1-4 postoperative

  15. Tolerability of Virtual Reality

    Questionnaire, interview

    Time frame: Day 1-4 postoperative

07

Study locations

1 site
  • Radboud university medical center
    Nijmegen, Netherlands
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03933124
Lead sponsor
Radboud University Medical Center
Responsible party
Sponsor
First posted
May 1, 2019
Start date
May 21, 2019
Primary completion
Feb 11, 2021
Completion
Feb 11, 2021
Last update
Sep 16, 2021

Study contacts

Harry van Goor, MD,PhD,FRCS
principal investigator · Radboud University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion